Skip to content

NEW LABPATHO

In bankruptcy Private limited company (pre-2019)founded 2007Place St Sébastien 56, 1420 Braine-l'AlleudKBO/BCE: BE 0889.587.790
NEW LABPATHO
Follow Report

Overview

Information for creditors

Enterprise Court of Walloon Brabant · Official Gazette of 30-09-2022
Appeal or third-party opposition 15-10-2022Filing the claim in RegSol 26-10-2022First verification report 07-11-2022Late claim 26-09-2023

Trustee: Christophe Chardon. The judgment is more than a year old. A claim can no longer be filed, not even late. The trustee knows whether anything will still be paid out.

Lifetime

14 annual accounts with figures on one time axis
peak €368,777 (2012)
-€20,700▲ €20,414
lowest -€209,942 (2017)
-€102,086▲ €54,349
peak €340,598 (2012)
-€574,551▼ €102,086
€900,345▲ 3.1%
peak 4.6 FTE (2015)
-not published
Board1 name since 2021
- 
Owners
100%LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE
Documentsfilings and deeds
24-08-202224 days late
2021micro format
Turnover from €346,190 to €135,635Gross margin from -€41,115 to -€20,700Loss of €102,086Dissolution of the company 03-12Equity from -€472,466 to -€574,551Cash from €15,063 to €1,803

Key points

from the 2021 annual accounts, the last ones filed

Equity

-€678,880 from €340,598 in 2012

Equity fell below zero in 2017.

Debts

€900,345 348% of the balance sheet
Financial debts 0%Suppliers 16%Taxes and wages 0%Other 83%

Filings

14 annual accounts 15 filings since 2008
deadline201020152020

Four of the last ten came late. The 2019 accounts came latest: 59 days after the end of the period.

No score

Board and ownership

FC
François Chalmagne, Réviseur d'Entreprises
Auditor, François CHALMAGNE
Board & ownership

Recent changes

Bankruptcy published Enterprise Court of Walloon Brabant · judgment of 26-09-2022 · Bankruptcy
Dissolution of the company Dissolved on 12-08-2021, in liquidation · Permanent representative: François CHALMAGNE · Appointment: François CHALMAGNE, Réviseur d'entreprises (company auditor) · General meeting of 12-08-2021 · Gazette deed
Incorporation 8 publications in the Belgian Official Gazette, the last on 03-12-2021 · published on 01-06-2007 · Gazette deed
All 21 events

Official details

Source: KBO
Status
In bankruptcydeclared bankrupt on 26-09-2022
Registered office
14 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 7 November 2026.
Activity
No activity registered in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2021

-€94,701▼ 357%
€104,329▲ 2.2%
-€678,880▼ 18.2%
€258,380▼ 20.7%
≈ 0 FTEestimated
Filing
Filed on 24-08-2022
Financials

Insights on NEW LABPATHO

Equity fell from €340,598 in 2012 to -€574,551 in 2021, while debts rose from €143,500 to €900,345.

On 26 September 2022 the court declared NEW LABPATHO bankrupt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2021

micro format, filed on 24-08-2022, 24 days late
-€94,701
▼ €53,586
-€102,056
▲ €52,067
-€95,734
▲ €42,570
-€98,007
▲ €42,609
-262.7%
▼ 144.9 percentage points
0.27
▼ 0.17

Money flows

no detail for 2021

Balance sheet

balance sheet total €258,380 on 31-12-2021
What the company ownsHow it is paid for

in euro

in euro

Staff

Staff costs divided by the average number of full-time equivalents.

people who joined people who left

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20212020201920182017201620152014201320122011201020092008
Balance sheet: assets
20/58 258,380400,776223,386151,770159,530179,263303,619357,083428,893493,398388,496267,672238,680350,898
21/28 8,55323,92539,74453,93777,22445,47763,44858,29625,49828,01941,14964,40489,626119,556
21 -1337811,4725,6675,445-3056102,9187,23010,01814,025
22/27 8,29223,65139,44553,59575,49024,54942,74243,0349,93212,14922,97041,91364,34790,271
23 8,01523,33839,09653,21066,9156,88015,4616,1426,3087,48916,22132,02051,31074,090
24 2773133493858,57617,66927,28136,8923,6244,6606,7499,89313,03716,181
28 26126126126126115,26115,26115,26115,26115,26115,26115,26115,26115,261
29/58 249,827376,851183,64297,83382,307133,787240,170298,788403,395465,378347,346203,267149,055231,342
3 -21,49621,49621,23315,157---------
30/36 -21,49621,49621,23315,157---------
40/41 249,668333,016156,02660,40644,37646,297154,282160,412139,912133,05498,89487,212105,114100,874
40 248,105327,671149,92560,38444,35843,838154,170110,05489,666133,05498,89487,212105,114100,874
41 1,5635,3456,10122182,45911250,35850,246-----
54/58 15915,0636,12114,01719,37282,87680,162133,235263,483328,608248,452116,05543,941130,467
490/1 07,276-2,1773,4014,6135,7265,141-3,716----
Balance sheet: equity and liabilities
10/49 258,380400,776223,386151,770159,530179,263303,619357,083428,893493,398388,496267,672238,680350,898
10/15 -678,880-472,466-316,031-247,698-89,912120,030222,673255,662328,867340,598209,212123,69664,85418,380
10/11 6,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,200
100 -18,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,600
101 -12,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,400
13 1,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,250
130/1 1,8601,860------------
130 --1,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,250
1311 1,8601,860------------
14 -686,940-480,526-324,091-255,758-97,972111,970214,613247,602320,807332,538201,152115,63656,79410,930
16 --2,0002,0002,0002,000---9,3009,300---
160/5 --2,0002,0002,0002,000---9,3009,300---
164/5 -02,0002,0002,0002,000--------
17/49 937,260873,242537,418397,468247,44257,23380,946101,421100,027143,500169,984143,976173,826332,518
17 3,72716,50429,28242,06066,5504,58615,47726,2095,27725,72545,15363,61281,15199,165
170/4 3,72716,50429,28242,06066,5504,58615,47726,2095,27725,72545,15363,61281,15199,165
42/48 933,533856,737508,136355,408180,89252,64765,46875,21394,749117,775118,42780,36389,675233,288
42 14,13512,77812,77812,7785,50011,79211,61916,72520,44819,42818,45917,53816,66314,482
44 146,764227,467137,639132,82481,82022,03916,91715,13330,68728,31928,2869,05010,96368,421
440/4 146,764227,467137,639132,82481,82022,03916,91715,13330,68728,31928,2869,05010,96368,421
45 1,4761301306,79993,57318,81736,93242,15843,61468,96071,68253,77562,04926,358
450/3 -130130012,5233,13610,5718,4498,92233,78349,36135,72937,7736,966
454/9 1,476--6,79981,05015,68026,36133,70934,69235,17622,32118,04624,27619,392
47/48 771,159616,362357,589203,008---1,197-1,068---124,027
492/3 ----------6,404-3,00065
Income statement
70 -346,190386,926-----------
9900 -94,701-41,11555,40724,600-16,66074,634165,551104,745171,785368,777320,813270,342286,423311,929
60/61 37,137387,305339,539-----------
62 85796,24191,761152,773161,785148,598174,678165,770178,648155,355155,025147,331180,049223,925
630 6,32215,81815,67425,11227,02622,38821,15712,6923,24613,13023,25526,74529,93144,896
631/4 -----765149-1,988-2,137-1,832-631,2683155,309
635/8 --2,000---2,000---9,300-9,300---
640/8 1751,4126169762,9721,2481,0345561,4581,1661,1421,1171,1152,536
66A -1,5377,406----40010,853-----
9901 -102,056-154,123-60,049-154,261-208,443-100,364-31,467-72,284-131200,958132,15493,88075,01235,261
75/76B --0121641452,0948523,3451685481,6731,568
75 --0121641452,0948523,3451685481,6731,568
65/66B 1,9992,3128,1543,4751,5192,2121,5332,4772,8724,0565,3415,4036,9127,853
65 1,9992,3128,1543,4751,5192,2121,5332,4772,8724,0565,3415,4036,9127,853
9903 -104,055-156,434-68,203-157,735-209,942-102,512-32,855-73,067-13,004200,247126,98189,02569,77428,977
67/77 274-13051-131135138-1,27368,86241,46530,18323,2997,197
9904 -104,329-156,434-68,334-157,786-209,942-102,643-32,989-73,205-11,731131,38685,51658,84246,47421,780
9905 -104,329-156,434-68,334-157,786-209,942-102,643-32,989-73,205-11,731131,38685,51658,84246,47421,780
Appropriation of the result
9906 -686,940-480,526-324,091-255,758-97,972111,970214,613247,602320,807332,538201,152115,63657,40421,780
14P -582,611-------------
691/2 ------------6101,250
6920 ------------6101,250
694/7 -------------9,600
695 -------------9,600
Social balance sheet
9087 -3.22.63.343.44.64.14.1443.84.13.9
Hours worked1013 -3,8533,8425,8736,3685,9707,4486,6807,2057,0906,7006,9787,21210,279
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2021 (PDF), filed on 24-08-2022.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2021 annual accounts filed 24 days after the deadline. Filed on 24 August 2022, deadline 31 July 2022 (7 months after the close on 31 December 2021, Companies Code art. 3:10). Source: NBB, 2022-20309654.

Financial year Type Filed Reference Document
31-12-2021 micro format 24-08-2022 2022-20309654 PDF
31-07-2021 micro format 24-08-2022 2022-20309653 PDF
31-12-2020 full format 05-08-2021 2021-46500044 PDF
31-12-2019 full format 28-09-2020 2020-56500047 PDF
31-12-2018 full format 05-08-2019 2019-43900361 PDF
31-12-2017 full format 27-06-2018 2018-24900440 PDF
31-12-2016 micro format 29-06-2017 2017-24200362 PDF
31-12-2015 full format 29-06-2016 2016-24700517 PDF
31-12-2014 full format 05-06-2015 2015-15300440 PDF
31-12-2013 full format 26-05-2014 2014-14200302 PDF
31-12-2012 full format 27-05-2013 2013-13300168 PDF
31-12-2011 full format 18-06-2012 2012-18300207 PDF
31-12-2010 full format 16-05-2011 2011-11300376 PDF
31-12-2009 full format 29-06-2010 2010-24900278 PDF
31-12-2008 full format 06-07-2009 2009-36400053 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20212020201920182017201620152014201320122011201020092008
-95,734-138,304-44,375-129,149-181,417-77,976-10,309-59,5923,115214,088155,409120,625104,94380,158
-98,007-140,616-52,659-132,674-182,916-80,255-11,832-60,512-8,485144,515108,77185,58776,40566,676
-9,05001,4811,82573,7734,41726,31045,489725001,5240164,453
-14,9048,942-7,897-5,355-63,5042,714-53,072-130,249-65,12580,156132,39772,114-86,527-
-683,706-479,886-324,493-257,575-98,58681,139174,702223,575308,646347,603228,920122,90459,379-1,947
--44.5%-15.5%-----------
-262.7%-117.9%-141.5%-163.2%-56.4%67.0%73.3%71.6%76.7%69.0%53.9%46.2%27.2%5.2%
0.270.440.360.280.462.543.673.974.263.952.932.531.660.99
0.270.410.320.220.372.543.673.974.263.952.932.531.660.99
-----0.480.360.400.300.420.811.162.6818.09
------85.5%-14.8%-28.6%-3.6%38.6%40.9%47.6%71.7%118.5%
-40.4%-39.0%-30.6%-104.0%-131.6%-57.3%-10.9%-20.5%-2.7%26.6%22.0%22.0%19.5%6.2%
-47.88-------------
-345 days141 days-----------
1442 days214 days148 days-----------

Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on NEW LABPATHO

The operating result for 2021 is a loss of €102,056, smaller than the loss of €154,123 in 2020.

Equity is negative. Debt (€937,260) exceeds the balance-sheet total (€258,380).

Large changes and their cause
  • 2017 Net result -105% on 2016. The accounts now follow the full format, last year the micro format.

Board & ownership

Curator

the curator has managed the company since 26-09-2022
Christophe Chardon
Curator, Avenue Du Cente- Naire 120, 1400 Nivelles
Also on 201 other cases

Last board

1 auditor
François Chalmagne, Réviseur d'Entreprises
Company auditor, permanent representative François CHALMAGNE
appointed by deed of 03-12-2021

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
François Chalmagne, Réviseur d'Entreprises
Company auditor
Bankruptcy 26-09-2022
Mandates as a list
  • François Chalmagne, Réviseur d'Entreprises
    • Company auditor, appointed by deed of 03-12-2021, until the bankruptcy of 26-09-2022

See the board, name and registered office on a given date →

Control

Shareholder in 2021
LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE
100%
This company
NEW LABPATHO
Equity -€678,880
Loss €104,329 in 2021

Capital

Contribution
€6,200
Source
2021 annual accounts

Owners through the years

as the annual accounts name them
LABORATOIRE DE L'INSTITUT MEDICAL SPECIALISE
100%
100%
Owners as a list

Source: lists of holdings in the owners' accounts

Timeline

Timeline

21 events since 2007
2022
Bankruptcy published Enterprise Court of Walloon Brabant · judgment of 26-09-2022
Annual accounts 2021 filed PDFmicro format · 177 days late
2021
Dissolution of the companyDissolved on 12-08-2021, in liquidation · Permanent representative: François CHALMAGNE · Appointment: François CHALMAGNE, Réviseur d'entreprises (company auditor) · General meeting of 12-08-20215 points ▸
  • General meeting, 12-08-2021
  • Permanent representative, François CHALMAGNE
  • Auditor appointment, François CHALMAGNE, Réviseur d'entreprises (company auditor)
  • Board meeting, 27-07-2021
  • Dissolution, 12-08-2021
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2020 filed PDFfull format · 5 days late
2020
Annual accounts 2019 filed PDFfull format · 59 days late
2019
Annual accounts 2018 filed PDFfull format · 5 days late
2018
Annual accounts 2017 filed PDFfull format · 34 days before the deadline
2017
Weakest financial year net -€209,942 The net result drops to -€209,942, the lowest from 2008 to 2021.
Annual accounts 2016 filed PDFmicro format · 32 days before the deadline
2016
Annual accounts 2015 filed PDFfull format · 32 days before the deadline
2015
Annual accounts 2014 filed PDFfull format · 56 days before the deadline
2014
Annual accounts 2013 filed PDFfull format · 66 days before the deadline
2013
Annual accounts 2012 filed PDFfull format · 65 days before the deadline
2012
Highest result from 2008 to 2021 net €131,386 ▲53.6% The operating result of €200,958 and the net result of €131,386 are both a record.
Annual accounts 2011 filed PDFfull format · 43 days before the deadline
2011
Equity above €200,000 equity €209,212 ▲69.1% With a profit in every financial year since 2008, equity grows to €209,212.
Annual accounts 2010 filed PDFfull format · 76 days before the deadline
2010
Equity above €100,000 equity €123,696 ▲90.7% With a profit in every financial year since 2008, equity grows to €123,696.
Annual accounts 2009 filed PDFfull format · 32 days before the deadline
2009
Annual accounts 2008 filed PDFfull format · 25 days before the deadline
2007
Incorporation PDF8 publications in the Belgian Official Gazette, the last on 03-12-2021 · published on 01-06-2007

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

NEW LABPATHO was incorporated on 15 May 2007.1 Turnover fell from €386,926 in 2019 to €135,635 in 2021 and headcount from 3.3 full-time equivalents in 2018 to 3.2 in 2020.2 On 26 September 2022 the company was declared bankrupt.3

  1. 1KBO register
  2. 2National Bank, annual accounts 2018, 2019, 2020 and 2021
  3. 3Belgian Official Gazette, 30-09-2022

Company details

Identity

Enterprise number
0889.587.790
VAT number
BE 0889.587.790
Legal form
Private limited company (pre-2019)
Status
In bankruptcy, since 26-09-2022
Founded
15-05-2007
Financial year
ends on 31 December
Peppol
Not found in the Peppol Directory
Name
NEW LABPATHO in French
Entity type
Legal entity

Registered office and establishments

Place St Sébastien 56 registered office 1420 Braine-l'Alleud

We would like to set cookies. That happens only with your consent. What we measure